Fan XX, Wu Q (2022) Decoding lung cancer at single-cell level. Front Immunol 13:883758

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hutchinson BD, Shroff GS, Truong MT, Ko JP (2019) Spectrum of lung adenocarcinoma. Semin Ultrasound CT MR 40:255–264

Article  PubMed  Google Scholar 

Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS (2021) Lung cancer. Lancet 398:535–554

Article  PubMed  Google Scholar 

Zhang Q, Xia T, Qi C, Du J, Ye C (2022) High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. BMC Cancer 22:77

Article  PubMed  PubMed Central  Google Scholar 

Wang H, Hu X, Yang F, Xiao H (2021) Mir-325-3p promotes the proliferation, invasion, and EMT of breast cancer cells by directly targeting S100A2. Oncol Res 28:731–744

Article  PubMed  PubMed Central  Google Scholar 

Li C, Chen Q, Zhou Y, Niu Y, Wang X, Li X et al (2020) S100A2 promotes glycolysis and proliferation via GLUT1 regulation in colorectal cancer. Faseb j 34:13333–13344

Article  CAS  PubMed  Google Scholar 

Hountis P, Matthaios D, Froudarakis M, Bouros D, Kakolyris S (2014) S100A2 protein and non-small cell lung cancer. The dual role concept. Tumour Biol 35:7327–7333

Article  CAS  PubMed  Google Scholar 

Sugino H, Sawada Y (2022) Influence of S100A2 in human diseases. Diagnostics. https://doi.org/10.3390/diagnostics12071756

Article  PubMed  PubMed Central  Google Scholar 

Zeng T, Ren W, Zeng H, Wang D, Wu X, Xu G (2024) Tfap2a activates S100A2 to mediate glutamine metabolism and promote lung adenocarcinoma metastasis. Clin Respir J 18:e13825

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan R, Liu Q, Segeren HA, Yuniati L, Guardavaccaro D, Lebbink RJ et al (2019) Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression. EMBO J 38:e101430

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo X, Liu L, Zhang Q, Yang W, Zhang Y (2020) E2F7 transcriptionally inhibits MicroRNA-199b expression to promote USP47, thereby enhancing colon cancer tumor stem cell activity and promoting the occurrence of colon cancer. Front Oncol 10:565449

Article  PubMed  Google Scholar 

Yang R, Wang M, Zhang G, Bao Y, Wu Y, Li X et al (2020) E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression. Br J Cancer 123:1445–1455

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu L, Li Z, Wu Y, Zhu T, Ma Z, Dong L et al (2023) Hsa-miR-195-5p inhibits autophagy and gemcitabine resistance of lung adenocarcinoma cells via E2F7/CEP55. Biochem Genet 61:1528–1547

Article  CAS  PubMed  Google Scholar 

Chen Y, Wang C, Song J, Xu R, Ruze R, Zhao Y (2021) S100A2 is a prognostic biomarker involved in immune infiltration and predict immunotherapy response in pancreatic cancer. Front Immunol 12:758004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Wang Z, Lin R, Huang S, Miao H, Zou L et al (2022) Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism. Biochem Pharmacol 205:115253

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

Article  CAS  PubMed  Google Scholar 

Cerezo M, Rocchi S (2020) Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy. Cell Death Dis 11:964

Article  PubMed  PubMed Central  Google Scholar 

Yu Q, Tu H, Yin X, Peng C, Dou C, Yang W et al (2022) Targeting glutamine metabolism ameliorates autoimmune hepatitis via inhibiting T cell activation and differentiation. Front Immunol 13:880262

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang R, Li X, Wu Y, Zhang G, Liu X, Li Y et al (2020) EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma. Oncogene 39:2975–2986

Article  CAS  PubMed  Google Scholar 

Akar S, Donmez-Altuntas H, Hamurcu Z (2022) β-escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene. Mol Biol Rep 49:7409–7415

Article  CAS  PubMed  Google Scholar 

Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC et al (2021) Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest. https://doi.org/10.1172/JCI140100

Article  PubMed  PubMed Central  Google Scholar 

Byun JK, Park M, Lee S, Yun JW, Lee J, Kim JS et al (2020) Inhibition of glutamine utilization synergizes with immune checkpoint inhibitor to promote antitumor immunity. Mol Cell 80:592-606.e8

Article  CAS  PubMed  Google Scholar 

Lemberg KM, Vornov JJ, Rais R, Slusher BS (2018) We’re Not “DON” Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine. Mol Cancer Ther 17:1824–1832

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Wang Z, Liang Z, Jin C, Shi Y, Fan M et al (2023) Nfic1 inhibits the migration and invasion of MDA-MB-231 cells through S100A2-mediated inactivation of MEK/ERK pathway. Arch Biochem Biophys 734:109497

Article  CAS  PubMed  Google Scholar 

Liu YF, Liu QQ, Wang X, Luo CH (2014) Clinical significance of S100A2 expression in gastric cancer. Tumour Biol 35:3731–3741

Article  CAS  PubMed  Google Scholar 

Han F, Zhang L, Liao S, Zhang Y, Qian L, Hou F et al (2022) The interaction between S100A2 and KPNA2 mediates NFYA nuclear import and is a novel therapeutic target for colorectal cancer metastasis. Oncogene 41:657–670

Article  CAS  PubMed  Google Scholar 

Feng G, Xu X, Youssef EM, Lotan R (2001) Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res 61:7999–8004

CAS  PubMed  Google Scholar 

Wang T, Liang Y, Thakur A, Zhang S, Liu F, Khan H et al (2017) Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity. Clin Chim Acta 464:118–122

Article  CAS  PubMed  Google Scholar 

Lin D, Zhao W, Yang J, Wang H, Zhang H (2022) Integrative analysis of biomarkers and mechanisms in adamantinomatous craniopharyngioma. Front Genet 13:830793

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiang S, Wang Z, Ye Y, Zhang F, Li H, Yang Y et al (2019) E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Oncogene 38:1269–1281

Article  CAS  PubMed  Google Scholar 

Ling S, Zhan Q, Jiang G, Shan Q, Yin L, Wang R et al (2022) E2F7 promotes mammalian target of ra